{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:51:09Z","timestamp":1791492669985,"version":"4.3.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtcvsonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jtcvs.2026.02.005","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T19:54:50Z","timestamp":1771358090000},"page":"591-599.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of GLP-1 inhibitors with cardiovascular outcomes in patients undergoing coronary artery bypass surgery"],"prefix":"10.1016","volume":"172","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8787-9841","authenticated-orcid":false,"given":"Irsa","family":"Hasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily G.","family":"Bessette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xander","family":"Jacquemyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathir","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zain","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floyd","family":"Thoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Ogami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Bonatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kaczorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Serna-Gallegos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jtcvs.2026.02.005_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.jtcvs.2026.02.005_bib2","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.jtcvs.2026.02.005_bib3","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jtcvs.2026.02.005_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jtcvs.2026.02.005_bib5","article-title":"Short-term effects of tirzepatide in Obese adults: a real-world prospective study","volume":"17","author":"Adamidis","year":"2025","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.02.005_bib6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00464-024-11263-2","article-title":"Multi-society clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period","volume":"39","author":"Kindel","year":"2025","journal-title":"Surg Endosc"},{"issue":"5","key":"10.1016\/j.jtcvs.2026.02.005_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.124.014961","article-title":"Efficacy of the glucagon-like Peptide-1 agonist exenatide in patients undergoing CABG or aortic valve replacement: a randomized double-blind clinical trial","volume":"18","author":"Kjaergaard","year":"2025","journal-title":"Circ Cardiovasc Interv"},{"issue":"Supplement_1","key":"10.1016\/j.jtcvs.2026.02.005_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae666.442","article-title":"Semaglutide and atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials","volume":"45","author":"Costa","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtcvs.2026.02.005_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwaf257","article-title":"Reduction of new onset of atrial fibrillation in patients treated with semaglutide: an updated systematic review and meta regression analysis of randomized controlled trials","author":"Cesaro","year":"2025","journal-title":"Eur J Prev Cardiol"},{"issue":"9989","key":"10.1016\/j.jtcvs.2026.02.005_bib10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","article-title":"50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study","volume":"386","author":"Schnabel","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jtcvs.2026.02.005_bib11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.amjcard.2021.08.042","article-title":"Prevention and treatment of atrial fibrillation via risk factor modification","volume":"160","author":"O'Keefe","year":"2021","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.jtcvs.2026.02.005_bib12","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1016\/j.hrthm.2025.03.1945","article-title":"Late-breaking clinical trials and science: clinical trials updates and registries II","volume":"22","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jtcvs.2026.02.005_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fcdhc.2023.1293926","article-title":"The benefits of GLP1 receptors in cardiovascular diseases","volume":"4","author":"Ferhatbegovic","year":"2023","journal-title":"Front Clin Diabetes Healthc"},{"key":"10.1016\/j.jtcvs.2026.02.005_bib14","article-title":"Role of glucagon-like peptide-1 agonist in patients undergoing percutaneous coronary intervention or coronary artery bypass grafting: a meta-analysis","volume":"11","author":"Ogbu","year":"2021","journal-title":"Am Heart J Plus"},{"issue":"6","key":"10.1016\/j.jtcvs.2026.02.005_bib15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jacc.2008.10.033","article-title":"Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury","volume":"53","author":"Timmers","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jtcvs.2026.02.005_bib16","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/dc19-1465","article-title":"Vasodilatory actions of glucagon-like peptide 1 are preserved in skeletal and cardiac muscle microvasculature but not in conduit artery in Obese humans with vascular insulin resistance","volume":"43","author":"Wang","year":"2020","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.jtcvs.2026.02.005_bib17","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.2337\/db05-1373","article-title":"Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle","volume":"55","author":"Clerk","year":"2006","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.02.005_bib18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.atssr.2025.09.024","article-title":"Do outcomes after cardiac surgery differ by preoperative status and socioeconomic deprivation?","volume":"4","author":"Grady","year":"2025","journal-title":"Ann Thorac Surg Short Rep"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.02.005_bib19","doi-asserted-by":"crossref","first-page":"20682","DOI":"10.1038\/s41598-024-71414-2","article-title":"A systematic review and meta-analysis of differences between men and women in short-term outcomes following coronary artery bypass graft surgery","volume":"14","author":"Dumitriu LaGrange","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.02.005_bib20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13019-020-01201-3","article-title":"The impact of age on outcomes of coronary artery bypass grafting","volume":"15","author":"Lemaire","year":"2020","journal-title":"J Cardiothorac Surg"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522326001145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522326001145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:40:08Z","timestamp":1791492008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522326001145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0022522326001145"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2026.02.005","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of GLP-1 inhibitors with cardiovascular outcomes in patients undergoing coronary artery bypass surgery","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2026.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by The American Association for Thoracic Surgery","name":"copyright","label":"Copyright"}]}}